Harmony Biosciences Holdings (HRMY) EPS (Diluted) (2019 - 2026)
Harmony Biosciences Holdings (HRMY) posted EPS (Diluted) of $1.28 for Q2 2026, up 88.6% from $0.68 a year earlier and up 132.3% from the prior quarter.
Powered by 
Analysis
Harmony Biosciences Holdings (HRMY) EPS (Diluted) (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EPS (Diluted) at Harmony Biosciences Holdings was $3.09, down 0.4% year-over-year; for FY2025, it was $2.71, up 7.8% from FY2024.
- In prior years, Harmony Biosciences Holdings' EPS (Diluted) was $2.51 in FY2024 (+17.8%), $2.13 in FY2023 (-28.1%), $2.97 in FY2022 (+408.3%) and $0.58 in FY2021.
- The Q2 2026 figure stands as the highest quarterly EPS (Diluted) since Q3 2022.
- On a year-over-year basis, EPS (Diluted) increased in six of the last eight quarters, with growth averaging 48.5%.
- The strongest year-over-year quarter for EPS (Diluted) in the past five years was Q2 2025, with growth of 238.0%; the weakest was Q2 2024, with a decline of 64.3%.
- According to Business Quant data, EPS (Diluted) for the three prior quarters was $0.55 (Q1 2026), $0.38 (Q4 2025) and $0.87 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.67 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.85 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -0.04 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 4.31 |
| 10 | Harmony Biosciences Holdings | 2.28 Bn | -474.81 Mn | 198.08 Mn | 1.28 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.28 |
| Mar 31, 2026 | 0.55 |
| Dec 31, 2025 | 0.38 |
| Sep 30, 2025 | 0.87 |
| Jun 30, 2025 | 0.68 |
| Mar 31, 2025 | 0.78 |
| Dec 31, 2024 | 0.85 |
| Sep 30, 2024 | 0.79 |
| Jun 30, 2024 | 0.20 |
| Mar 31, 2024 | 0.67 |
| Dec 31, 2023 | 0.44 |
| Sep 30, 2023 | 0.63 |
| Jun 30, 2023 | 0.56 |
| Mar 31, 2023 | 0.48 |
| Dec 31, 2022 | 0.79 |
| Sep 30, 2022 | 1.44 |
| Jun 30, 2022 | 0.39 |
| Mar 31, 2022 | 0.35 |
| Dec 31, 2021 | 0.38 |
| Sep 30, 2021 | -0.17 |
API Access
Harmony Biosciences Holdings EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=HRMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();